Free Trial

Rep. Josh Gottheimer Sells Endava plc (NYSE:DAVA) Shares

Endava logo with Computer and Technology background

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Endava plc NYSE: DAVA. In a filing disclosed on April 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Endava stock on March 19th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Spotify Technology NYSE: SPOT on 3/24/2025.
  • Purchased $1,001 - $15,000 in shares of Visa NYSE: V on 3/24/2025.
  • Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Pacific Premier Bancorp NASDAQ: PPBI on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Azenta NASDAQ: AZTA on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Crinetics Pharmaceuticals NASDAQ: CRNX on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Chord Energy NASDAQ: CHRD on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/19/2025.
  • Sold $1,001 - $15,000 in shares of Tri Pointe Homes NYSE: TPH on 3/19/2025.

Endava Price Performance

Shares of Endava stock traded down $0.31 on Friday, reaching $17.09. The company's stock had a trading volume of 391,212 shares, compared to its average volume of 483,587. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $1.01 billion, a P/E ratio of 155.36, a PEG ratio of 2.26 and a beta of 1.33. The stock has a 50-day moving average price of $22.42 and a 200-day moving average price of $26.67. Endava plc has a 52-week low of $16.70 and a 52-week high of $34.94.

Endava (NYSE:DAVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.18). The company had revenue of $250.63 million during the quarter, compared to analysts' expectations of $197.33 million. Endava had a return on equity of 0.89% and a net margin of 0.74%. Analysts expect that Endava plc will post 0.57 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Needham & Company LLC cut their price objective on Endava from $43.00 to $38.00 and set a "buy" rating for the company in a research note on Friday, February 21st. Morgan Stanley increased their price objective on Endava from $33.00 to $35.00 and gave the company an "equal weight" rating in a research note on Friday, January 31st. Finally, Susquehanna lowered their target price on shares of Endava from $55.00 to $50.00 and set a "positive" rating on the stock in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Endava currently has an average rating of "Moderate Buy" and a consensus target price of $39.10.

Get Our Latest Analysis on Endava

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in DAVA. State Street Corp raised its position in Endava by 33.0% in the third quarter. State Street Corp now owns 80,148 shares of the company's stock valued at $2,047,000 after purchasing an additional 19,884 shares during the period. Oppenheimer Asset Management Inc. acquired a new stake in shares of Endava during the 4th quarter worth about $215,000. Robeco Institutional Asset Management B.V. raised its holdings in Endava by 13.9% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 204,300 shares of the company's stock valued at $6,313,000 after buying an additional 25,000 shares during the period. Natixis Advisors LLC boosted its stake in Endava by 44.8% during the fourth quarter. Natixis Advisors LLC now owns 45,340 shares of the company's stock worth $1,401,000 after buying an additional 14,023 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in Endava by 35.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 27,289 shares of the company's stock worth $843,000 after buying an additional 7,124 shares during the period. 62.23% of the stock is currently owned by institutional investors and hedge funds.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2026 election. Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Endava Company Profile

(Get Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Featured Articles

Should You Invest $1,000 in Endava Right Now?

Before you consider Endava, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.

While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines